---
figid: PMC2254474__11302_2006_Article_9008_Fig1
figtitle: P2Y receptor-mediated signalling cascades in C6 cells
organisms:
- NA
pmcid: PMC2254474
filename: 11302_2006_Article_9008_Fig1.jpg
figlink: /pmc/articles/PMC2254474/figure/Fig1/
number: F1
caption: Overview of P2Y receptor-mediated signalling cascades in C6 cells. Green
  and red lines represent stimulatory (green arrows) and inhibitory (red squares)
  actions respectively. Dashed lines are incomplete characterised pathways. P2Y2 receptor
  stimulation enhances ERK-dependent proliferation through a PLC-dependent pathway
  while P2Y12 receptor stimulation enhances cell proliferation by RhoA- and PKCζ-dependent
  activation of ERK (Claes et al. []; Grobben et al. []; Tu et al. []; Van Kolen and
  Slegers, unpublished data). P2Y12 receptor stimulation also inhibits cAMP-dependent
  induction of differentiation by reactivation of PKB which requires Src/Pyk2 complex
  formation and Rap1 activation. Formation of the Src/Pyk2 complex requires Ca2+ and
  PLD2 which is constitutively active (Claes et al. []; Van Kolen and Slegers [];
  Van Kolen et al. []). Cyclic AMP-dependent inhibition of PKB and ERK is suggested
  to depend on inhibition of Rap1 (Wang et al. []). The negative modulation of PI
  3-K by the P2Y1 receptor is only displayed in the presence of serum (Czajkowski
  et al. [])
papertitle: Integration of P2Y receptor-activated signal transduction pathways in
  G protein-dependent signalling networks.
reftext: Kristof Van Kolen, et al. Purinergic Signal. 2006 Sep;2(3):451-469.
year: '2006'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8872384
figid_alias: PMC2254474__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC2254474__F1
ndex: 97005fdc-df16-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2254474__11302_2006_Article_9008_Fig1.html
  '@type': Dataset
  description: Overview of P2Y receptor-mediated signalling cascades in C6 cells.
    Green and red lines represent stimulatory (green arrows) and inhibitory (red squares)
    actions respectively. Dashed lines are incomplete characterised pathways. P2Y2
    receptor stimulation enhances ERK-dependent proliferation through a PLC-dependent
    pathway while P2Y12 receptor stimulation enhances cell proliferation by RhoA-
    and PKCζ-dependent activation of ERK (Claes et al. []; Grobben et al. []; Tu et
    al. []; Van Kolen and Slegers, unpublished data). P2Y12 receptor stimulation also
    inhibits cAMP-dependent induction of differentiation by reactivation of PKB which
    requires Src/Pyk2 complex formation and Rap1 activation. Formation of the Src/Pyk2
    complex requires Ca2+ and PLD2 which is constitutively active (Claes et al. [];
    Van Kolen and Slegers []; Van Kolen et al. []). Cyclic AMP-dependent inhibition
    of PKB and ERK is suggested to depend on inhibition of Rap1 (Wang et al. []).
    The negative modulation of PI 3-K by the P2Y1 receptor is only displayed in the
    presence of serum (Czajkowski et al. [])
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ado
  - ATPsynbeta
  - Atpalpha
  - btl
  - adp
  - Ne
  - B-H2
  - B-H1
  - hh
  - .na.character
  - ca
  - ras
  - Ras64B
  - Ras85D
  - ra
  - Sos
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - pi
  - ac
  - IRSp53
  - IleRS
  - chico
  - drk
  - Akt
  - Pdk
  - Pdk1
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Rho1
  - Rap1
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Elk
  - Jra
  - sgg
  - DCTN6-p27
  - dap
  - CG9588
  - Cdk4
  - CycD
  - LanB2
  - anon-70Db
  - ADO
  - ATP8A2
  - IGF1R
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PDGFRB
  - PDGFRA
  - WDTC1
  - P2RY12
  - ADRB2
  - NR1H4
  - BFAR
  - PI3
  - KRAS
  - HRAS
  - NRAS
  - MKI67
  - XYLT2
  - SOS1
  - SOS2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - GRB2
  - AKT1
  - PTK2B
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - PRKCA
  - PRRT2
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - RHOA
  - RASSF5
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - EPHB1
  - KCNH8
  - OGDH
  - GFAP
  - JUN
  - JUNB
  - JUND
  - GSK3A
  - GSK3B
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - CCND1
  - CCND2
  - CCND3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
